Skip to main content
TipRanks
Go Ultimate75% OFF

Northwest Biotherapeutics (NBYB) Balance Sheet

0 Followers

Northwest Biotherapeutics Balance Sheet

Northwest Biotherapeutics's total assets for Q3 2026 were $76.14M, an increase of 0.26% from the previous quarter. DE:NBYB total liabilities were $122.44M for the fiscal quarter, a 10.59% an increase from the previous quarter. See a summary of the company’s assets, liabilities, and equity.

Balance Sheet
Balance SheetDec 25Dec 24Dec 23Dec 22Dec 21
$ 81.29M$ 26.73M$ 27.86M$ 31.32M$ 40.16M
$ 128.86M$ 105.71M$ 74.92M$ 159.43M$ 164.15M
$ -47.57M$ -94.49M$ -47.05M$ -128.10M$ -123.99M

Currency in USD

Northwest Biotherapeutics Liabilities to Assets

0150M300M450M0 %500 %1000 %1500 %LiabilitiesLiabilities to Assets201720182019202020212022202320242025AssetsLiabilitiesLiabilities to Assets